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Brief Report
Population-Based Birth Defects Data in the United States,
2008 to 2012: Presentation of State-Specific Data and
Descriptive Brief on Variability of Prevalence
Cara T. Mai*1, Jennifer Isenburg1,2, Peter H. Langlois3, CJ Alverson1, Suzanne M. Gilboa1,
Russel Rickard4, Mark A. Canfield3, Suzanne B. Anjohrin5, Philip J. Lupo6,
Deanna R. Jackson1, Erin B. Stallings1,2, Angela E. Scheuerle3,7, Russell S. Kirby8
for the National Birth Defects Prevention Network
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Introduction
Major structural birth defects collectively affect 3 to 5% of
births in the United States and contribute substantially to
mortality and morbidity (CDC, 2008; TDSHS, 2015). Since
2000, the National Birth Defects Prevention Network
(NBDPN) has annually published state-specific data for
selected major birth defects affecting a range of organ systems, including central nervous, eye, ear, cardiovascular,
orofacial, gastrointestinal, genitourinary, and musculoskeletal, as well as chromosomal and other conditions, such as
amniotic bands. While the NBPDN list of birth defects had
remained relatively unchanged for two decades, it was
recently revised and released with the 2014 NBDPN
Annual Report (Mai et al., 2014). Several factors necessitated an in-depth examination of the list of conditions: (1)
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development of national data quality standards for birth
defects surveillance in the United States; (2) transition of
the diagnostic coding system from the International Classification of Diseases, 9th Revision, Clinical Modification
(ICD-9-CM) to ICD-10-CM; and (3) inclusion of newborn
screening for critical congenital heart defects (CCHD), with
12 primary and secondary CCHD targets, on the national
Recommended Uniform Screening Panel. The revision process included a review of each condition in relation to its
public health importance, state of current knowledge, and
clinical factors, such as accuracy of diagnosis within a
child’s first year of life. Table 1 presents the revised list of
birth defects and their diagnostic codes [ICD-9-CM and
Centers for Disease Control and Prevention/British Pediatric Association Classification of Diseases (CDC/BPA)].
The data component of the 2015 NBDPN Annual Report
comprises: (1) state-specific data from 41 population-based
birth defects surveillance programs for the 47 major birth
defects listed in Table 1; (2) a directory of state birth defects
surveillance programs, which details data collection, surveillance methodology, and birth defects contacts; and (3) a
descriptive data brief further highlighting the variability in
prevalence estimates across population-based birth defects
programs.

State-Specific Data Collection and Presentation
of 47 Major Birth Defects
Starting in February 2015, the NBDPN Data Committee,
in collaboration with CDC, reviewed and refined the data
collection process. This included updating the data dictionary and determining the focus of the data brief. A
call for data was then issued in April 2015 to
population-based birth defects surveillance programs in
the United States. Programs were asked to submit data
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TABLE 1. National Birth Defects Prevention Network (NBDPN) List of Reported
Birth Defects by Disease Classification Codes

973

TABLE 1. Continued

Disease classification codes
Disease classification codes

International
Classification
of Diseases,
9th Revision,
Clinical Modification
(ICD-9-CM)

Centers for
Disease Control
and Prevention/British
Pediatric Association
Classification
of Diseases
(CDC/BPA)

Anencephaly

740.0 – 740.1

740.00 – 740.10

Spina bifida without

741.0, 741.9

741.00 – 741.99

without

without

screeninga

740.0 - 740.1

740.00 – 740.10

Birth defects
Central nervous system

anencephaly

Birth defects
Tricuspid valve atresia

International
Classification
of Diseases,
9th Revision,
Clinical Modification
(ICD-9-CM)

Centers for
Disease Control
and Prevention/British
Pediatric Association
Classification
of Diseases
(CDC/BPA)

746.1

746.100, 746.106

and stenosis
Tricuspid valve

(excluding 746.105)
746.1

746.100

atresia– for CCHD

Ebstein anomaly

746.2

746.20

Encephalocele

742.0

742.00 – 742.09

Aortic valve stenosis

746.3

746.30

Holoprosencephaly

742.2

742.26

Hypoplastic left heart

746.7

746.70

Coarctation of aorta

747.10

747.10 – 747.19

Total anomalous

747.41

747.42

Eye
Anophthalmia/

syndrome
743.0, 743.1

743.00 – 743.10

microphthalmia
Congenital cataract

743.30 – 743.34

743.32

744.01, 744.23

744.01, 744.21

Ear
Anotia/microtia

connection

Cardiovascular
Common truncus

745.0

(truncus arteriosus)
Transposition of the

745.00
(excluding 745.01)

745.10, .12, .19

great arteries (TGA)
dextro-Transposition

pulmonary venous

745.10

Single ventricle

745.3

745.3

Interrupted aortic arch

747.11

747.215 – 747.217

Double outlet right

745.11

745.13 – 745.15

749.0

749.00 – 749.09

749.1

749.10 – 749.19

749.20-749.25

749.20 – 749.29

748.0

748.00

750.3

750.30 – 750.35

751.2

751.20 – 751.24

Biliary atresia

751.61

751.65

Small intestinal atre-

751.1

751.10 – 751.19

ventricle

745.10 – 745.12,

Orofacial

745.18 – 745.19

Cleft palate alone

745.10, 745.11,745.19

of great arteries (d-

(without cleft lip)
Cleft lip alone (without

TGA) – for CCHD

cleft palate)

screeninga

Cleft lip with cleft

Tetralogy of Fallot

745.2

745.20 – 745.21, 747.31

Ventricular septal

745.4

745.40 – 745.49

Choanal atresia

(excluding 745.487,

Gastrointestinal

defect

745.498)
Atrial septal defect
Atrioventricular septal

745.5

745.51 – 745.59

745.60, .61, .69

745.60 – 745.69, 745.487

defect (endocardial

– or CCHD
screeninga

tracheoesophageal
fistula

intestinal atresia/
746.01, 746.02

746.00, 746.01

atresia and stenosis
Pulmonary valve atresia

Esophageal atresia/

Rectal and large

cushion defect)
Pulmonary valve

palate

746.01

746.00

stenosis

sia/stenosis
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TABLE 1. Continued

Disease classification codes

Birth defects

International
Classification
of Diseases,
9th Revision,
Clinical Modification
(ICD-9-CM)

Centers for
Disease Control
and Prevention/British
Pediatric Association
Classification
of Diseases
(CDC/BPA)

753.0

753.00 – 753.01

Genitourinary
Renal agenesis/
hypoplasia
Bladder exstrophy

753.5

Hypospadias

752.61

753.50
752.60 – 752.62
(excluding 752.61
and 752.621)

Congenital posterior

753.6

753.60

751.5

751.555

756.73

756.71

urethral valves
Cloacal exstrophy
Musculoskeletal
Gastroschisis

(as of 10/1/09)
Omphalocele

756.72

756.70

(as of 10/1/09)
Diaphragmatic hernia

756.6

756.610 – 756.617

755.2 – 755.4

755.20 – 755.49

Craniosynostosis

No specific code

756.00 – 756.03

Clubfoot

754.51, 754.70

Limb deficiencies
(reduction defects)

754.50, 754.73
(excluding 754.735)

Chromosomal
Trisomy 13

758.1

758.10 – 758.19

Trisomy 21

758.0

758.00 – 758.09

(Down syndrome)
Trisomy 18

758.2

758.20 – 758.29

Turner syndrome

758.6

758.60 – 758.69

Deletion 22q11.2

758.32

758.37

a

The primary targets for CCHD screening include seven conditions:
hypoplastic left heart syndrome, pulmonary atresia with intact septum, tetralogy of Fallot, total anomalous pulmonary venous connection, dextro-transposition of great arteries (d-TGA), tricuspid atresia,
and truncus arteriosus. The NBDPN traditionally monitors all TGA,
and both atresia and stenosis for pulmonary and tricuspid valve conditions; however, for CCHD screening reporting purpose, these conditions are also reported as d-TGA, pulmonary valve atresia, and
tricuspid valve atresia.

CCHD, critical congenital heart defect.

using templates provided in Excel or SAS (SAS Institute,
Inc., Cary, NC). CDC performed data quality checks, and
state programs validated their data and approved final
data table presentation.
Participating birth defects surveillance programs submitted case counts of the reportable birth defects shown
in Table 1 and the number of live births occurring from
January 1, 2008 through December 31, 2012. These cases
were stratified by U.S. Census maternal racial/ethnic
groups: non-Hispanic white, non-Hispanic black, Hispanic,
non-Hispanic Asian/Pacific Islander, non-Hispanic American Indian/Alaska Native, and other/unknown. Additionally, as maternal age is strongly associated with selected
trisomies and gastroschisis, case counts for these defects
were submitted stratified by maternal age at delivery in
six categories: less than 20 years, 20 to 24 years, 25 to 29
years, 30 to 34 years, 35 to 39 years, and 40 1 years.
STATE-SPECIFIC DATA PRESENTATION

State-specific data from 41 population-based birth defects
surveillance programs for 2008 to 2012 are shown electronically at Supporting Information. The data are presented
in two tables for each state program. The first table shows
birth defect counts and prevalence per 10,000 live births
by maternal racial/ethnic categories. The second table
presents counts and prevalence for trisomies and gastroschisis by two maternal age categories (less than 35 years,
35 1 years). The prevalence is calculated by dividing the
number of birth defect cases for any pregnancy outcome by
the total number of live births for the reported years and
then multiplying by 10,000 (Mason et al., 2005). The
denominator used to calculate the prevalence for all birth
defects is total live births except for hypospadias and
Turner syndrome, which are calculated using total male live
births and total female live births, respectively.
State-specific notes and clarifications about the data,
such as methodologic changes and inclusion of probable/
possible diagnoses, are included in the data tables. Additional information about each state program methodology
is available in the accompanying birth defects program
directory.

Descriptive Data Brief on Observed Variability in
Prevalence Estimates Across Population-Based
Birth Defects Programs
This descriptive data brief includes prevalence-based summaries for birth defects listed in Table 1 from 38 of the 41
population-based birth defects surveillance programs contributing data to this report (three programs were
excluded in the data brief due to their level of data aggregation). State programs were grouped by their case-finding
approach (active or passive). The 15 programs in the
active case-finding category were: Arizona, Arkansas, Delaware, Georgia (metropolitan Atlanta), Iowa, Louisiana,
Massachusetts, Minnesota, New Hampshire, North Carolina,
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Oklahoma, Puerto Rico, South Carolina, Texas, and Utah;
23 programs in the passive case-finding category were:
Colorado, Florida, Illinois, Indiana, Kansas, Kentucky, Maine,
Maryland, Michigan, Mississippi, Missouri, Nebraska, Nevada,
New Jersey, New Mexico, New York, Oregon, Rhode Island,
Tennessee, Vermont, Virginia, West Virginia, and Wisconsin.
The defects are displayed by organ system (Tables 2A:
central nervous; 2B: ear and eye; 2C: cardiovascular; 2D:
orofacial; 2E: gastrointestinal; 2F: genitourinary; 2G: musculoskeletal; and 2H: chromosomal). Within each organ system, the conditions are then presented, when possible, in
order by the magnitude of the distribution of the prevalence estimates submitted from the 38 birth defects surveillance programs.
For each of the 47 defects, we present prevalence-based
summary statistics by case-finding approach (total, active,
passive) and by maternal race/ethnicity groups (white nonHispanic, black non-Hispanic, Hispanic, and all race/ethnicity combined). Of note, for these analyses the state-specific
data are not pooled across state programs. The mean prevalence is calculated as the mean of the individual state prevalences, with each state weighted equally, regardless of
population size. We describe the range of state-specific
prevalence estimates by presenting the mean, Chebyshev
interval (mean 6 two standard deviations) (Berenson et al.,
2012), median (P50), inter-decile interval [10th percentile
(P10), 90th percentile (P90)], and inter-quartile interval
[25th percentile (P25), 75th percentile (P75)]. The mean and
median describe the central tendency of the set of statespecific prevalence estimates, and the intervals describe the
variation of the set of state-specific prevalence estimates.
Specifically, the Chebyshev interval, a useful metric for nonnormal distributions, captures at least 75% of its statespecific prevalence estimates. Each inter-quartile interval
captures approximately 50% of the state-specific prevalence
estimates, and the inter-decile interval captures approximately 80% of the state-specific prevalence estimates.
While the inter-quartile interval is more familiar, the interdecile interval is a better companion to the Chebyshev interval because they capture similar proportions of the statespecific prevalence estimates; thus both interval measures
were included in the data tables. For example, 38 state programs contributed data for anencephaly with a mean prevalence estimate of 1.7 cases/10,000 live births (LB), with at
least 75% of these 38 program prevalence estimates
between 0.0 and 3.8 cases/10,000 LB (Chebyshev interval).
The overall median is 1.5 cases/10,000 LB, and approximately 80% of these 38 estimates are between 0.3 and 3.0
cases/10,000 LB (inter-decile percentile interval). With
respect to the inter-quartile percentile interval, approximately 50% of the 38 estimates are between 0.9 and 2.5
cases/10,000 LB.
The data tables include corresponding boxplots whose
vertical widths are weighted to correspond to the race/
ethnicity distribution of birth defects cases for non-

975

Hispanic white, non-Hispanic black, and Hispanic (displayed from top to bottom, respectively). Figure 1 details
the components of the boxplots.
Additional data presentations are included for trisomies
and gastroschisis by three maternal age categories (<25
years, 25–34 years, and 35 1 years) in Tables 3A and 3B,
respectively. These tables use the same descriptive measures for central tendency and dispersion as the maternal
race/ethnicity tables (i.e., mean, Chebyshev interval,
median, inter-decile interval, and inter-quartile interval).
SELECTED HIGHLIGHTS OF BIRTH DEFECTS-SPECIFIC VARIABILITY
Central nervous system defects (Table 2A). While the average

(mean or median) prevalence estimates of anencephaly
and spina bifida were highest among Hispanics across all
programs, more variability was observed for this group
compared with non-Hispanic whites and non-Hispanic
blacks. For anencephaly, the Chebyshev interval for Hispanics was 0.0 to 7.9 cases/10,000 LB while the interval
was 0.0 to 3.5 cases/10,000 LB for non-Hispanic whites
and 0.0 to 4.1 cases/10,000 for non-Hispanic blacks. Anencephaly also exhibited higher overall prevalence and
greater variability among programs with active casefinding compared with passive case-finding. In contrast,
the case-finding approach appeared to have little impact
on both average prevalence and variability of spina bifida.
Passive case-finding programs generally had higher
prevalence estimates than active case-finding programs for
holoprosencephaly, but the dispersion in these estimates
was much wider (Chebyshev interval 0.0–6.6 cases/10,000
LB) for the passive compared with active case-finding programs (0.3–2.5 cases/10,000 LB).
Eye and ear defects (Table 2B). The average prevalence and dispersion for the eye defects, anophthalmia/microphthalmia
and congenital cataract, were relatively similar across the
racial/ethnic groups (non-Hispanic whites, Hispanics, and
non-Hispanic blacks). However, the active-case finding programs reported somewhat higher average prevalence estimates. Less dispersion in the prevalence estimates was
observed for anophthalmia/microphthalmia than for congenital cataract.
The state prevalence estimates for anotia/microtia
among Hispanics showed much more variability than other
race/ethnicity groups (Chebyshev interval 0.0–8.4 cases/
10,000 LB for Hispanics compared with 0.0–3.0 and 0.0–
3.6 cases/10,000 LB for non-Hispanic whites and nonHispanic blacks, respectively). While active case-finding
programs reported approximately 50% higher prevalence
estimates, this was accompanied by a wider dispersion
around the mean and median values.

The mean prevalence estimates
reported were highest among non-Hispanic blacks for several cardiac conditions (interrupted aortic arch, atrioventricular septal defect [AVSD], tetralogy of Fallot); however,
some of the higher observed differences were attenuated
Cardiovascular defects (Table 2C).

TABLE 2A. Central Nervous System Defects Prevalence Estimates (Prevalence Per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-Finding Methodology and Maternal Race/ethnicity,
2008–2012.
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TABLE 2B. Eye and Ear Defects Prevalence Estimates (Prevalence Per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-Finding Methodology and Maternal Race/ethnicity, 2008–2012.

BIRTH DEFECTS RESEARCH (PART A) 103:972–994 (2015)
977

TABLE 2C. Cardiovascular Defects Prevalence Estimates (Prevalence Per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-Finding Methodology and Maternal Race/ethnicity, 2008–
2012.
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TABLE 2C. Continued
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TABLE 2C. Continued
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TABLE 2C. Continued
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TABLE 2D. Orofacial Defects Prevalence Estimates (Prevalence per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-finding Methodology and Maternal Race/Ethnicity, 2008–2012.
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TABLE 2E. Gastrointestinal Defects Prevalence Estimates (Prevalence per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-finding Methodology & Maternal Race/Ethnicity, 2008–2012.
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TABLE 2F. Genitourinary Defects Prevalence Estimates (Prevalence per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-finding Methodology and Maternal Race/Ethnicity, 2008–2012.
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when examining the median values. For example, the prevalence estimate for interrupted aortic arch among nonHispanic blacks shifted from a mean of 0.8 cases/10,000
LB to a median of 0.5 cases/10,000 LB, which was closer
to the estimates for the other groups. Other birth defects
(e.g., single ventricle, tricuspid valve atresia and stenosis,
pulmonary valve atresia and stenosis) also seemed to have
higher mean prevalence estimates among non-Hispanic
blacks, but had wide overlapping inter-quartile ranges.
Higher average prevalence among non-Hispanic whites
was observed for aortic valve stenosis and coarctation of
the aorta, and higher average prevalence among Hispanics
for total anomalous pulmonary venous return.
Active case-finding programs reported relatively similar
or higher average prevalence estimates for most cardiac
conditions on the NBDPN birth defects list except for atrial
septal defect. The average prevalence estimates for this
condition were higher for passive case-finding programs,
and this was accompanied by wide dispersion. For example, the Chebyshev interval for atrial septal defect was 0.0
to 204.6 cases/10,000 LB for passive case-finding programs compared with 0.0 to 74.4 cases/10,000 LB. A similar pattern did not emerge for ventricular septal defect.
For AVSD, active case-finding programs had substantially
higher average prevalence across all three racial/ethnic
groups than passive case-finding programs, with barely
any overlap in the inter-quartile ranges. However, the dispersion was similar between active and passive programs.
Orofacial defects (Table 2D). Little variation was observed in the
average prevalence for choanal atresia across case-finding
programs or racial/ethnic groups. Among clefts, nonHispanic blacks consistently showed the lowest average
prevalence for all types of orofacial clefts (cleft lip alone,
cleft lip with cleft palate, and cleft palate alone). The casefinding approach did not appear to impact the average
prevalence of orofacial conditions or the spread of state
prevalence values.

Even with relatively wide dispersions, the average prevalence estimates were similar
among racial/ethnic groups except among non-Hispanic
blacks. Among this group, slightly higher average prevalence for biliary atresia and lower average prevalence for
rectal and large intestinal atresia/stenosis, were noted.
While the prevalence estimates observed for the four
gastrointestinal defects on the NBDPN list were similar
across case-finding programs, the inter-quartile intervals
from active case-finding programs were narrower than
those of passive case-finding programs.
TABLE 2F. Continued

Gastrointestinal defects (Table 2E).

Compared with non-Hispanic
whites and blacks, Hispanics had a higher prevalence of
bladder exstrophy and renal agenesis/hypoplasia (in the
active case-finding programs). However, the dispersion in
the prevalence estimates was relatively wide. In fact, for
the estimates for renal agenesis/hypoplasia among
Genitourinary defects (Table 2F).

TABLE 2G. Musculoskeletal Defects Prevalence Estimates (Prevalence per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-finding Methodology and Maternal Race/Ethnicity, 2008–
2012.
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TABLE 2G. Continued
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TABLE 2H. Chromosomal Defects Prevalence Estimates (Prevalence per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-finding Methodology and Maternal Race/Ethnicity, 2008–2012
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Hispanics, the Chebyshev interval was five times higher
for active case-finding programs (0–36.3 cases/10,000 LB)
compared with passive case-finding programs (0–7.4
cases/10,000 LB). The average prevalence of congenital
posterior urethral valves was higher among non-Hispanic
blacks. Hispanics appeared to have a consistently lower
prevalence of hypospadias.
The reported average prevalence for hypospadias and
cloacal exstrophy were higher among states with passive
case-finding ascertainment, but much of this was driven
by a large dispersion. For example, the Chebyshev interval for cloacal exstrophy was 16 times wider for passive
case-finding programs (0.0–8.3 cases/10,000 LB) compared with active case-finding programs (0.0–0.5 cases/
10,000 LB).
In general, average prevalence
was similar across race/ethnic groups with the exception of
omphalocele, which appeared to be higher among nonHispanic blacks. Active case-finding programs reported
higher average prevalence for clubfoot and omphalocele. For
clubfoot, active case-finding programs not only reported
higher prevalence estimates, but also less variability (mean
of 16.7 cases/10,000 LB and Chebyshev interval of 12.7–
20.8 cases/10,000 LB) compared with passive case-finding
programs (mean of 11.7 cases/10,000LB and Chebyshev
interval of 1.6–21.7 cases/10,000 LB).
As one of the new conditions added to the NBDPN list,
craniosynostosis was reported by only 15 programs for
this data brief. Active case-finding programs had much
higher prevalence estimates across all three racial/ethnic
groups, especially for non-Hispanic whites, with only a
slight overlap in the inter-quartile ranges. The variations
observed in the prevalence estimates appeared to be sensitive to extreme values (wide dispersion observed using the
Chebyshev intervals but with tighter inter-quartile ranges).
Musculoskeletal defects (Table 2G).

TABLE 2H. Continued

Chromosomal conditions (Table 2H). Hispanics seemed to have
slightly higher average prevalence of trisomy 21; nonHispanic blacks seemed to have slightly higher average prevalence of trisomies 13 and 18. The variability in the raceethnicity specific estimates, however, is substantial, especially for trisomy 18, both between active and passive casefinding programs and within the group of states conducting
active ascertainment. Active case-finding programs generally
reported higher average prevalence for chromosomal conditions, but showed a wider inter-quartile dispersion except
for deletion 22 q11.2, where the range was extremely narrow (0.8–0.9 cases/10,000 LB).
Maternal age (Tables 3A and 3B). The prevalence estimates for
all three trisomy conditions were slightly higher among
active case-finding programs, with a pronounced jump in
prevalence estimates for older mothers (35 years), especially for Down syndrome. The variability in the prevalence estimates for trisomies 13 and 18 was markedly
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FIGURE 1. Legend for the graphs in
the data tables.

larger among the programs with active case-finding than
programs with passive case-finding.
For gastroschisis, the average prevalence estimates were
highest among young mothers (<25 years), with the overall
magnitude of and variability in prevalence estimates relatively consistent across surveillance case-finding approaches.

Discussion
Population-based birth defects surveillance systems in the
United States are generally established at the state level.
The NBDPN has published state-specific birth defects
counts and prevalence estimates for a range of major birth
defects for almost two decades, but has increasingly focused
its efforts on multi-state collaborative projects using pooled
data to characterize the prevalence and public health burden, survival, and health outcomes of affected populations.
The expanded utility of state-based birth defects data warrants a closer examination of the variability behind prevalence estimates for specific birth defects across programs.
This report attempts to broadly describe variations
observed in birth defects data across 38 population-based
surveillance systems by examining two measures of central
tendency (mean and median) and the accompanying dispersion measures (standard deviations around the mean values
and inter-quartile and inter-decile intervals around median
values). Much of the variability observed can likely be
explained by (1) clinical practice and coding and (2) surveillance ascertainment methodology.
CLINICAL PRACTICE AND CODING

Population-based birth defects surveillance data are largely
removed from direct medical care. Clinical practice and
patient access to health care can affect how information is
recorded in medical records. Prenatal care may be immediate, delayed, or absent which impacts the health of the
pregnancy and whether (and when) a birth defect is identified and recorded. After delivery, differences in the level of
hospital care, screening practices, and diagnostic capabilities

among birthing facilities could affect which birth defects are
detected and documented in medical records.
The quantity and quality of information ascertained
from medical records and how diagnostic case information
is coded can greatly affect the variations in prevalence
estimates observed for several birth defects. For example,
the wide dispersion observed in the average prevalence
estimates for atrial septal defects among passive casefinding programs is likely driven by those programs’ reliance on administrative datasets to ascertain cases using
an imprecise ICD-9-CM code that often times include other
conditions, such as patent foramen ovale.
Other issues such as diagnostic certainty of conditions, and
whether a program can definitively confirm cases, can affect
observed variations. Salemi et al. (2012) compared the passive
case ascertainment methodology used by the Florida Birth
Defects Registry with an enhanced system that used hospital
medical record review, and concluded that for epidemiologic or
clinical studies, the program should implement a more comprehensive case ascertainment strategy that includes case
confirmation.
SURVEILLANCE ASCERTAINMENT METHODOLOGY

Surveillance ascertainment methodology, specifically how programs find cases, which pregnancy outcomes are included,
and the type of data sources accessed, are critical drivers of
variability of prevalence estimates. Hobbs et al. (2001) noted
several potential sources of variability in case ascertainment
methods, data sources, case inclusion criteria, inclusion of
elective terminations and stillbirths, age limit, and diagnostic
confirmation and precision.
The ability of birth defects surveillance programs to
capture cases from all pregnancy outcomes is important,
but capturing this data can be challenging. Whereas most
systems capture both live births and fetal deaths, only
approximately 40% are able to capture terminations of
pregnancy (Mai et al., 2015). For some conditions, the lack
of other pregnancy outcomes can greatly affect data

TABLE 3A. Trisomy Prevalence Estimates (Prevalence Per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-Finding Methodology and Maternal Age, 2008–2012.
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TABLE 3B. Gastrochisis Prevalence Estimates (Prevalence Per 10,000 Live Births): Measures of Central Tendency and Dispersion by Case-Finding Methodology and Maternal Age, 2008–2012.

992

completeness. Cragan and Gilboa (2009) found that adding
prenatal sources from perinatologists’ offices to their data
sources increased the total defect prevalence by approximately 7% (28 per 1000 to 30 per 1000). The increase
was most pronounced for lethal conditions, such as anencephaly. In general, active case-finding programs report
higher average prevalence estimates, but this is most likely
driven by inclusion of all pregnancy outcomes.
Wide variations can be observed for rare events within
a small population size. The occurrence of some individual
types of birth defects can be considered rare, and when the
counts are stratified further into subgroups, such as maternal race/ethnicity, some extreme variations are observed.
For example, among active case-finding programs, the mean
prevalence estimate for tetralogy of Fallot among Hispanics
is almost twice the median prevalence estimate, due to
extreme right skewness (Chebyshev interval 0.0–33.2
cases/10,000 LB). This result is driven by one program that
ascertained a few cases from a small Hispanic LB population (less than 1000 LB over a 5-year period).
Pooling data from multiple state programs for epidemiologic and etiologic studies assists in reducing certain
extreme-values challenges. Examples of studies using pooled
data include the NBDPN national estimates project and the
National Birth Defects Prevention Study. The NBDPN developed national estimates using pooled data from programs
that could confirm 100% of the cases (Canfield et al., 2006;
Parker et al., 2010). Likewise, the National Birth Defects Prevention Study, one of the largest case-control studies to
examine risk factors for birth defects, used pooled birth
defects data from 10 population-based birth defects surveillance programs that all followed a rigid study protocol for
case inclusion (Reefhuis et al., 2015; Dolk, 2015).
CONCLUSIONS

Given a lack of a national system for population-based birth
defects surveillance, multi-state data collaborations are important to address the public health impact of birth defects in the
United States. As the utility of population-based birth defects
surveillance data increases with applications for policy decisions, prevention efforts and the development of a research
agenda, understanding the variability behind prevalence estimates for specific birth defects across states is key. True variation in occurrence is expected because populations have
different underlying risks; however our organizational experience has shown that some sources of variation are controllable.
The NBDPN released national standards for data quality in
2014 that included performance measures around completeness, timeliness and accuracy of birth defects data (Anderka
et al., in press). Implementation of those standards across surveillance systems will be an important step forward in controlling variability. Concerted efforts are needed to continue to
improve birth defects surveillance across population-based
programs.
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